In this Review, Sopko and Burnett summarize strategies to mitigate adverse penile remodelling and protect erectile function in men undergoing prostatectomy. They discuss innovations for surgery, the use of phosphodiesterase type 5 inhibitors, intracavernosal injections and vacuum erection devices, as well as possible future treatments. Multidisciplinary approaches are required, but the best therapy scheme has not yet been identified.
- Nikolai A. Sopko
- Arthur L. Burnett
